Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
XEN103
Cat. No.:
OB0425LY-038
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
XEN103 is a selective SCD1 inhibitor that inhibits mSCD1 and SCD1 in HepG2 cell.
Synonyms:
840489-44-3; XEN 103; N-(2-Cyclopropylethyl)-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridazine-3-carboxamide; N-(2-Cyclopropylethyl)-6-(4-(5-fluoro-2-(trifluoromethyl)benzoyl)piperazin-1-yl)pyridazine-3-carboxamide
CAS No.:
840489-44-3
Compound CID:
16035876
Formula:
C22H23F4N5O2
Formula Weight:
465.44
Specification
Target:
Stearoyl-CoA desaturase (SCD)
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
XEN103 can be used to evaluate its potential efficacy in disease (obesity, diabetes) models.
